Pfizer (PFE) agreed to buy Seagen (SGEN) for $43B. Stewart Glickman discusses this as CFRA has a buy rating on PFE. The CFRA analyst notes that they expect the deal to close by early 2024, dependent on both shareholder and regulatory approval. They think that the market is pricing in some concern over antitrust hurdles. He then goes over other health care stocks to watch. Tune in to find out more about the stock market today.
The Watch List
14 Mar 2023
SHARE
Market On Close
18 Dec 2023
Morning Trade Live
23 Jan 2024
Market On Close
09 Jan 2024
Morning Trade Live
14 Dec 2023
The Watch List
01 Feb 2024
Morning Trade Live
12 Feb 2024